Results 211 to 220 of about 3,811,568 (245)
Some of the next articles are maybe not open access.
Enzalutamide in Castration-Resistant Prostate Cancer
New England Journal of Medicine, 2018Giacomo, Bregni +2 more
openaire +4 more sources
Olaparib for Metastatic Castration-Resistant Prostate Cancer
New England Journal of Medicine, 2020Bivas, Biswas +2 more
openaire +8 more sources
New Therapies for Castration-Resistant Prostate Cancer
New England Journal of Medicine, 2010On April 29, 2010, the Food and Drug Administration (FDA) approved a new immunotherapy, sipuleucel-T, for the treatment of patients with asymptomatic or minimally symptomatic castration-resistant prostate cancer. Traditionally, immune-based therapies have been categorized according to whether the agent has direct antitumor effects (so-called passive ...
openaire +2 more sources
Denosumab in castration-resistant prostate cancer
The Lancet, 2012Athanassios, Kyrgidis +1 more
openaire +2 more sources
Genetic testing in prostate cancer management: Considerations informing primary care
Ca-A Cancer Journal for Clinicians, 2022Todd M Morgan +2 more
exaly